Physician

Daniel Arthur Watrous, M.D.

According to 2025 Medicare claims, Daniel Watrous, M.D. (NPI: 1841246568) practices rheumatology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES-CA PC (NPI: 1770933723; TIN: 812957590) and primary practice location at 93291-5118. Watrous is affiliated with the MountainStar Care Partners ACO (ACO ID: A5181), participating under the MSSP model.

Watrous' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,300 traditional Medicare patients, billed 368,812 HCPCS/CPT codes, and received $5,206,460 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,257 prescription claims across 327 beneficiaries totaling $1,090,185 in drug costs, led by Enbrel Sureclick (Etanercept). 2023 DME data shows 26 claims. Open Payments data shows 146 records totaling $2,971. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,281,715 and ending at $1,090,185. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,593 to $8,596.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,184	193,221	$3,955,937
2016	1,179	185,321	$4,279,784
2017	1,184	200,507	$4,284,578
2018	1,200	205,387	$4,610,264
2019	1,217	219,777	$4,564,872
2020	1,081	226,637	$5,196,083
2021	1,122	222,961	$5,394,044
2022	1,228	227,819	$5,038,304
2023	1,321	277,136	$5,385,963
2024	1,300	368,812	$5,206,460

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	755	7,015	$1,281,715
2016	761	6,772	$1,655,953
2017	724	4,598	$1,484,803
2018	681	3,542	$2,104,625
2019	672	3,134	$1,243,356
2020	566	2,641	$1,820,900
2021	567	2,654	$3,753,061
2022	479	2,157	$3,546,536
2023	378	1,430	$1,615,714
2024	327	1,257	$1,090,185

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$8,623
2016	N/R	N/R	N/R
2017	N/R	14	$23
2018	N/R	N/R	N/R
2019	N/R	12	$18,517
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$546
2023	N/R	26	$705
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	288	288	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,015	3,407	$95
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	219	1,128	$52
J0897	Injection, denosumab, 1 mg	186	16,860	$21
96372	Injection of drug or substance under skin or into muscle	392	1,325	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	23	652	$166,148
Enbrel Mini	Etanercept	15	420	$98,349
Rinvoq	Upadacitinib	16	480	$97,225
Cimzia (2 Pack)	Certolizumab Pegol	11	308	$60,419
Methotrexate	Methotrexate Sodium	240	8,158	$3,431

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	146	$2,971	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Arthur Watrous, M.D.?

Tedicare shows public-source Medicare data for Daniel Arthur Watrous, M.D. (NPI 1841246568), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Arthur Watrous, M.D. have ACO affiliation data?

Daniel Arthur Watrous, M.D. is shown with ACO affiliation data for MountainStar Care Partners ACO (MSSP, ACO ID A5181).

What billing organization is linked to Daniel Arthur Watrous, M.D.?

Daniel Arthur Watrous, M.D. is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES-CA PC (billing NPI 1770933723) in the available physician profile data.

Does Daniel Arthur Watrous, M.D. have Open Payments data?

Daniel Arthur Watrous, M.D. has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.